Tocagen (TOCA) Reports Q1 Loss of $0.65
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Tocagen Reports First Quarter 2018 Financial and Business Results
May 10, 2018 4:05 PM EDTSAN DIEGO, May 10, 2018 /PRNewswire/ --Â Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today reported financial results and business highlights for the first quarter ended March 31, 2018.
"We are off to a strong start this year and are well... More
